Vectorite Biomedical Inc. (TPEX:4170)
Taiwan · Delayed Price · Currency is TWD 12.50
+0.10 (0.81%)
Jul 14, 2026, 1:50 PM CST
Vectorite Biomedical Market Cap
Vectorite Biomedical has a market cap or net worth of 547.14 million as of July 14, 2026. Its market cap has increased by 0.40% in one year.
Market Cap
547.14M
Enterprise Value
377.28M
Revenue
61.41M
Ranking
n/a
PE Ratio
5.71
Stock Price
12.50
Market Cap Chart
Since April 15, 2013, Vectorite Biomedical's market cap has increased from 393.23M to 547.14M, an increase of 39.14%. That is a compound annual growth rate of 2.52%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 14, 2026 | 547.14M | -10.71% |
| Dec 31, 2025 | 612.80M | -3.45% |
| Dec 31, 2024 | 634.68M | -32.08% |
| Dec 29, 2023 | 934.52M | 49.34% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| U-Neuron Biomedical | 973.67M |
| Meribank Biotech | 964.56M |
| GeneReach Biotechnology | 956.96M |
| Taiwan Advance Bio-Pharmaceutical | 891.90M |
| NatureWise Biotech & Medicals | 820.23M |
| BioLASCO Taiwan | 752.99M |
| MegaPro Biomedical | 734.58M |
| SynCore Biotechnology Co.,Ltd | 710.32M |